Stay updated on Cabiralizumab Combo in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-06T18:01:51.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page shows a system revision update: added Revision: v3.4.2 and removed Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:36:45.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 was removed from the Study Protocol/Statistical Analysis Plan section.
    Difference
    0.0%
    Check dated 2026-02-05T18:53:34.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.3.4 appears and v3.3.3 is removed. This is a minor metadata update that does not change the study details.
    Difference
    0.0%
    Check dated 2026-01-15T03:16:19.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The study record now includes a Locations section with multiple site locations (Arizona, California, Colorado, Florida, Maryland, Massachusetts, Missouri, New York, Pennsylvania, Tennessee, Texas, Washington, Alberta, Ontario, Chiba, Tokyo, Lanarkshire). The previous location listings were removed, and the revision is v3.3.3.
    Difference
    1%
    Check dated 2025-12-24T14:50:58.000Z thumbnail image
  8. Check
    112 days ago
    Change Detected
    Summary
    Revision: v3.3.2 has been added and Revision: v3.2.0 has been removed. This update pertains to versioning and does not modify any study data, eligibility criteria, or listed locations.
    Difference
    0.0%
    Check dated 2025-11-25T14:45:00.000Z thumbnail image

Stay in the know with updates to Cabiralizumab Combo in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page.